Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Cash from Investing Activities (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Cash from Investing Activities for 15 consecutive years, with $10.7 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 138.28% to $10.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 90.22% year-over-year, with the annual reading at $1.3 million for FY2025, 90.22% down from the prior year.
  • Cash from Investing Activities hit $10.7 million in Q4 2025 for Cardiff Oncology, up from $10.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $18.4 million in Q1 2022 to a low of -$111.7 million in Q1 2021.
  • Historically, Cash from Investing Activities has averaged -$2.1 million across 5 years, with a median of $6.1 million in 2022.
  • Biggest YoY gain for Cash from Investing Activities was 5326.62% in 2021; the steepest drop was 15328.07% in 2021.
  • Year by year, Cash from Investing Activities stood at -$8.8 million in 2021, then skyrocketed by 179.83% to $7.0 million in 2022, then soared by 93.18% to $13.6 million in 2023, then tumbled by 66.74% to $4.5 million in 2024, then soared by 138.28% to $10.7 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CRDF at $10.7 million in Q4 2025, $10.2 million in Q3 2025, and -$5.0 million in Q2 2025.